Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder
Abstract
Background Atomoxetine, a highly selective noradrenaline reuptake inhibitor (SNRI), shows efficacy in the treatment of attention-deficit/hyperactivity disorder (ADHD). Compared with psychostimulants, atomoxetine has a distinct mode of brain action and potentially lower addictive potential. Studies have yet to assess whether atomoxetine improves cognition following a single oral dose in ADHD. Methods Twenty-two adults with DSM-IV ADHD were administered a single oral dose of atomoxetine (60 mg) in a placebo-controlled double-blind crossover design. Cognitive effects were assessed using stop-signal, sustained attention, spatial working memory, and set-shifting paradigms. Normative cognitive data from 20 healthy volunteers were collected for comparison. Results The ADHD patients under placebo conditions showed response inhibition and working memory deficits compared with healthy volunteers. Atomoxetine treatment in the ADHD patients was associated with shorter stop-signal reaction times and lower numbers of commission errors on the sustained attention task. Conclusions Atomoxetine improved inhibitory control, most likely via noradrenergically mediated augmentation of prefrontal cortex function. These results have implications for understanding the mechanisms by which atomoxetine exerts beneficial clinical effects and suggest novel treatment directions for other disorders of impulsivity.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In humans, both normal subjects and patients with ADHD show improved PFC inhibition of behavior following atomoxetine, consistent with the animal data.
“In humans, both normal subjects (Chamberlain et al., 2006), and patients with ADHD (Chamberlain et al., 2007) show improved PFC inhibition of behavior following atomoxetine, consistent with the animal data.”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Chamberlain et al., 2007
Atomoxetine improves measures of PFC cognitive function in rats, monkeys, and humans.
“Atomoxetine improves measures of PFC cognitive function in rats (Newman et al., 2008; Robinson et al., 2008; Seu et al., 2009), monkeys (Gamo et al., 2010; Seu et al., 2009), and humans (Chamberlain et al., 2007; Chamberlain et al., 2006).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Chamberlain et al., 2007
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139 · see citing works
Statistical Methods for Psychology.
Gudgeon, A. C., & Howell, D. C. (1994) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2348956 · Cited by 8,277 · see citing works
The mini international neuropsychiatric interview
Lecrubier, Y., Sheehan, D. V., Hergueta, T., & Weiller, E. (1998) · European Psychiatry · doi:10.1016/s0924-9338(99)80239-9 · Cited by 5,882 · see citing works
Evenden, J. L. (1999) · Psychopharmacology · doi:10.1007/pl00005481 · Cited by 2,044 · see citing works
Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans
Aron, A. R., Fletcher, P. C., Bullmore, E. T., Sahakian, B. J., & Robbins, T. W. (2003) · Nature Neuroscience · doi:10.1038/nn1003 · Cited by 1,771 · see citing works
Self-citationPrinciples of Frontal Lobe Function
Stuss, D. T. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134971.001.0001 · Cited by 1,708 · see citing works
Aron, A. R., & Poldrack, R. A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4682-05.2006 · Cited by 1,630 · see citing works
Attention-Deficit/Hyperactivity Disorder: A Selective Overview
Biederman, J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.020 · Cited by 1,343 · see citing works
MARTINUSSEN, R., HAYDEN, J., HOGG-JOHNSON, S., & TANNOCK, R. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000153228.72591.73 · Cited by 1,297 · see citing works
Planning and spatial working memory following frontal lobe lesions in man
Owen, A. M., Downes, J. J., Sahakian, B. J., Polkey, C. E., & Robbins, T. W. (1990) · Neuropsychologia · doi:10.1016/0028-3932(90)90137-d · Cited by 1,241 · see citing works
Self-citationAttention-deficit hyperactivity disorder : a clinical workbook
Barkley, R. A., & Murphy, K. R. (1991) · Cited by 1,144 · see citing works
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123 · see citing works
Aron, A. R., Behrens, T. E., Smith, S., Frank, M. J., & Poldrack, R. A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0519-07.2007 · Cited by 982 · see citing works
Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions
Arnsten, A. F. T., & Li, B.-M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.019 · Cited by 948 · see citing works
Coull, J. T. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00011-2 · Cited by 882 · see citing works
BIEDERMAN, J., MONUTEAUX, M. C., MICK, E., SPENCER, T., WILENS, T. E., SILVA, J. M., SNYDER, L. E., & FARAONE, S. V. (2006) · Psychological Medicine · doi:10.1017/s0033291705006410 · Cited by 850 · see citing works
Chamberlain, S. R., Blackwell, A. D., Fineberg, N. A., Robbins, T. W., & Sahakian, B. J. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.11.006 · Cited by 830 · see citing works
Self-citationAtomoxetine in adults with ADHD: two randomized, placebo-controlled studies
Michelson, D., Adler, L., Spencer, T., Reimherr, F. W., West, S. A., Allen, A. J., Kelsey, D., Wernicke, J., Dietrich, A., & Milton, D. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01671-2 · Cited by 790 · see citing works
ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN ADULTS
Wender, P. H. (1998) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70039-3 · Cited by 728 · see citing works
Neurocognitive enhancement: what can we do and what should we do?
Farah, M. J., Illes, J., Cook-Deegan, R. M., Gardner, H., Kandel, E. R., King, P., Parens, E., Sahakian, B. J., & Wolpe, P. R. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1390 · Cited by 653 · see citing works
Self-citationMotor Inhibition and Cognitive Flexibility in Obsessive-Compulsive Disorder and Trichotillomania
Chamberlain, S. R., Fineberg, N. A., Blackwell, A. D., Robbins, T. W., & Sahakian, B. J. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.7.1282 · Cited by 627 · see citing works
Self-citationDifferential patterns of striatal activation in young children with and without ADHD
Durston, S., Tottenham, N. T., Thomas, K. M., Davidson, M. C., Eigsti, I.-M., Yang, Y., Ulug, A. M., & Casey, B. J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01904-2 · Cited by 619 · see citing works
Aron, A. R., & Poldrack, R. A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.026 · Cited by 602 · see citing works
Lijffijt, M., Kenemans, J. L., Verbaten, M. N., & van Engeland, H. (2005) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.114.2.216 · Cited by 592 · see citing works
Neurochemical Modulation of Response Inhibition and Probabilistic Learning in Humans
Chamberlain, S. R., Müller, U., Blackwell, A. D., Clark, L., Robbins, T. W., & Sahakian, B. J. (2006) · Science · doi:10.1126/science.1121218 · Cited by 573 · see citing works
Self-citationExecutive functioning in adult ADHD: a meta-analytic review
MARIJE BOONSTRA, A., OOSTERLAAN, J., SERGEANT, J. A., & BUITELAAR, J. K. (2005) · Psychological Medicine · doi:10.1017/s003329170500499x · Cited by 560 · see citing works
Rubia, K., Smith, A. B., Brammer, M. J., Toone, B., & Taylor, E. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1067 · Cited by 537 · see citing works
Cognitive enhancing effects of modafinil in healthy volunteers
Turner, D. C., Robbins, T. W., Clark, L., Aron, A. R., Dowson, J. H., & Sahakian, B. J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1250-8 · Cited by 518 · see citing works
Self-citationAttention-deficit/hyperactivity disorder (adhd) as a noradrenergic disorder
Biederman, J., & Spencer, T. J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00192-4 · Cited by 513 · see citing works
Principles of frontal lobe function
Jellinger, K. A. (2003) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00507_2.x · Cited by 434 · see citing works
Salivary alpha amylase as marker for adrenergic activity during stress: Effect of betablockade
van Stegeren, A., Rohleder, N., Everaerd, W., & Wolf, O. T. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.05.012 · Cited by 419 · see citing works
The neuropsychiatry of impulsivity
Chamberlain, S. R., & Sahakian, B. J. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3280ba4989 · Cited by 419 · see citing works
Self-citationIntra-Subject Variability in Attention-Deficit Hyperactivity Disorder
Klein, C., Wendling, K., Huettner, P., Ruder, H., & Peper, M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.003 · Cited by 410 · see citing works
Attention-deficit hyperactivity disorder: A clinical workbook, 2nd ed.
Barkley, R. A., & Murphy, K. R. (1998) · Cited by 403 · see citing works
McGough, J. J., Smalley, S. L., McCracken, J. T., YANG, M. H., Del’Homme, M., Lynn, D. E., & Loo, S. K. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.9.1621 · Cited by 398 · see citing works
Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder
Aron, A. R., Dowson, J. H., Sahakian, B. J., & Robbins, T. W. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00609-7 · Cited by 392 · see citing works
Self-citationArnsten, A., Cai, J., & Goldman-Rakic, P. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-11-04287.1988 · Cited by 391 · see citing works
Fundamentals of Attention-Deficit/Hyperactivity Disorder: Circuits and Pathways
Arnsten, A. F. T. (2006) · The Primary Care Companion to The Journal of Clinical Psychiatry · Cited by 380 · see citing works
Arnsten, A. F., & Dudley, A. G. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-2 · Cited by 363 · see citing works
Effectiveness and Tolerability of Tomoxetine in Adults With Attention Deficit Hyperactivity Disorder
Spencer, T., Biederman, J., Wilens, T. E., Prince, J., Hatch, M., Jones, J. T., CRAWFORD, M. H., Faraone, S. V., & Seidman, L. J. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.5.693 · Cited by 336 · see citing works
Applications of fMRI in translational medicine and clinical practice
Matthews, P. M., Honey, G. D., & Bullmore, E. T. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1929 · Cited by 323 · see citing works
Tryptophan depletion in normal volunteers produces selective impairments in learning and memory
Park, S. B., Coull, J. T., McShane, R. H., Young, A. H., Sahakian, B. J., Robbins, T. W., & Cowen, P. J. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90089-2 · Cited by 310 · see citing works
Self-citationTurner, D. C., Clark, L., Dowson, J., Robbins, T. W., & Sahakian, B. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.008 · Cited by 301 · see citing works
Self-citationDiagnosis and evaluation of adults with attention-deficit/hyperactivity disorder
Adler, L., & Cohen, J. (2004) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2003.12.003 · Cited by 290 · see citing works
Effects of methylphenidate on inhibitory control in hyperactive children
Tannock, R., Schachar, R. J., Carr, R. P., Chajczyk, D., & Logan, G. D. (1989) · Research on Child and Adolescent Psychopathology · doi:10.1007/bf00916508 · Cited by 289 · see citing works
Neuropsychological function in adults with attention-deficit hyperactivity disorder
Seidman, L. J., Biederman, J., Weber, W. J., Hatch, M., & Faraone, S. V. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00392-2 · Cited by 284 · see citing works
Anckarsäter, H., Stahlberg, O., Larson, T., Hakansson, C., Jutblad, S.-B., Niklasson, L., Nydén, A., Wentz, E., Westergren, S., Cloninger, C. R., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.7.1239 · Cited by 271 · see citing works
Mehta, M. A., Goodyer, I. M., & Sahakian, B. J. (2004) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2004.00221.x · Cited by 257 · see citing works
Self-citationClinical Pharmacokinetics of Atomoxetine
Sauer, J., Ring, B. J., & Witcher, J. W. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544060-00002 · Cited by 249 · see citing works
Evidence of Familial Association Between Attention Deficit Disorder and Major Affective Disorders
Biederman, J. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810310051009 · Cited by 228 · see citing works
Coull, J. T., Frackowiak, R. S. J., & Frith, C. (1998) · Neuropsychologia · doi:10.1016/s0028-3932(98)00035-9 · Cited by 225 · see citing works
Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders
Allen, A. J., Kurlan, R. M., Gilbert, D. L., Coffey, B. J., Linder, S. L., Lewis, D. W., Winner, P. K., Dunn, D. W., Dure, L. S., Sallee, F. R., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000188869.58300.a7 · Cited by 225 · see citing works
Mehta, M. A., Sahakian, B. J., McKenna, P. J., & Robbins, T. W. (1999) · Psychopharmacology · doi:10.1007/s002130051102 · Cited by 223 · see citing works
Self-citationEffects of Atomoxetine and Methylphenidate on Sleep in Children With ADHD
Sangal, R. B., Owens, J., Allen, A. J., Sutton, V., Schuh, K., & Kelsey, D. (2006) · Sleep · doi:10.1093/sleep/29.12.1573 · Cited by 214 · see citing works
Fischer, M., Barkley, R. A., Smallish, L., & Fletcher, K. (2007) · Accident Analysis & Prevention · doi:10.1016/j.aap.2006.06.008 · Cited by 200 · see citing works
Heil, S. H., Holmes, H., Bickel, W. K., Higgins, S. T., Badger, G. J., Laws, H. F., & Faries, D. E. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00053-4 · Cited by 198 · see citing works
Mehta, M. A., Manes, F. F., Magnolfi, G., Sahakian, B. J., & Robbins, T. W. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1899-2 · Cited by 196 · see citing works
Self-citationFamilial association between attention deficit disorder and anxiety disorders
Biederman, J., Faraone, S. V., Keenan, K. E., Steingard, R., & Tsuang, M. T. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.2.251 · Cited by 194 · see citing works
Cardiovascular Effects of Atomoxetine in Children, Adolescents, and Adults
Wernicke, J. F., Faries, D., Girod, D., Brown, J. W., Gao, H., Kelsey, D., Quintana, H., Lipetz, R., Michelson, D., & Heiligenstein, J. (2003) · Drug Safety · doi:10.2165/00002018-200326100-00006 · Cited by 191 · see citing works
Cortical noradrenaline, attention and arousal
Robbins, T. W. (1984) · Psychological Medicine · doi:10.1017/s0033291700003032 · Cited by 180 · see citing works
Self-citationKonrad, K., Günther, T., Hanisch, C., & Herpertz‐Dahlmann, B. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200402000-00015 · Cited by 179 · see citing works
Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
Wilens, T. E. (2006) · PubMed · Cited by 179 · see citing works
Eagle, D. M., Tufft, M. R. A., Goodchild, H. L., & Robbins, T. W. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0701-7 · Cited by 176 · see citing works
Self-citationThe Run on Ritalin: Attention Deficit Disorder and Stimulant Treatment in the 1990s
Diller, L. H. (1996) · The Hastings Center Report · doi:10.2307/3528571 · Cited by 172 · see citing works
Noradrenaline and attention lapses
Smith, A. P., & Nutt, D. (1996) · Nature · doi:10.1038/380291a0 · Cited by 170 · see citing works
Noradrenergic modulation of working memory and emotional memory in humans
Chamberlain, S. R., Müller, U., Blackwell, A. D., Robbins, T. W., & Sahakian, B. J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0391-6 · Cited by 170 · see citing works
Self-citationListening in Silence Activates Auditory Areas: A Functional Magnetic Resonance Imaging Study
Voisin, J., Bidet-Caulet, A., Bertrand, O., & Fonlupt, P. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2967-05.2006 · Cited by 170 · see citing works
Adler, L. A., Spencer, T. J., Milton, D. R., Moore, R. J., & Michelson, D. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0304 · Cited by 157 · see citing works
M. Robertson*, M. (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-006-0505-z · Cited by 143 · see citing works
Characteristic neurocognitive profile associated with adult attention-deficit/hyperactivity disorder
McLean, A., Dowson, J., Toone, B., Young, S., Bazanis, E., Robbins, T., & Sahakian, B. (2004) · Psychological Medicine · doi:10.1017/s0033291703001296 · Cited by 142 · see citing works
Self-citationOvertoom, C. C. E., Verbaten, M. N., Kemner, C., Kenemans, J. L., van Engeland, H., Buitelaar, J. K., van der Molen, M. W., van der Gugten, J., Westenberg, H. G. M., Maes, R. A. A., et al. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00097-4 · Cited by 138 · see citing works
Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder
Turner, D. C., Blackwell, A. D., Dowson, J. H., McLean, A., & Sahakian, B. J. (2005) · Psychopharmacology · doi:10.1007/s00213-004-1993-5 · Cited by 127 · see citing works
Self-citationDimensional Analysis of ADHD Subtypes in Rats
Blondeau, C., & Dellu-Hagedorn, F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.030 · Cited by 126 · see citing works
Disentangling Deficits in Adults With Attention-Deficit/Hyperactivity Disorder
Bekker, E. M., Overtoom, C. C. E., Kooij, J. J. S., Buitelaar, J. K., Verbaten, M. N., & Kenemans, J. L. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.10.1129 · Cited by 112 · see citing works
Dowson, J. H., McLean, A. N., Bazanis, E., Toone, B. K., Young, S., Robbins, T. W., & Sahakian, B. J. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00292.x · Cited by 111 · see citing works
Self-citationFaraone, S. V., Biederman, J., Spencer, T., Michelson, D., Adler, L., Reimherr, F., & Glatt, S. J. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-16 · Cited by 108 · see citing works
Stopping and changing in adults with ADHD
BEKKER, E. M., OVERTOOM, C. C., KENEMANS, J. L., KOOIJ, J. J., DE NOORD, I., BUITELAAR, J. K., & VERBATEN, M. N. (2005) · Psychological Medicine · doi:10.1017/s0033291704003459 · Cited by 101 · see citing works
Erenberg, G. (2005) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2005.12.003 · Cited by 98 · see citing works
Lifting the Veil on Trichotillomania
Chamberlain, S. R., Menzies, L. A., Sahakian, B. J., & Fineberg, N. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.4.568 · Cited by 98 · see citing works
Self-citationAtomoxetine, a Novel Treatment for Attention‐Deficit—Hyperactivity Disorder
Christman, A. K., Fermo, J. D., & Markowitz, J. S. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.11.1020.36146 · Cited by 97 · see citing works
Gilbert, D. L., Ridel, K. R., Sallee, F. R., Zhang, J., Lipps, T. D., & Wassermann, E. M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300806 · Cited by 97 · see citing works
Locomotor hyperactivity induced by blockade of prefrontal cortical α2-adrenoceptors in monkeys
Ma, C.-L., Arnsten, A. F. T., & Li, B.-M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.004 · Cited by 96 · see citing works
Neuropsychological function in adults with attention-deficit/hyperactivity disorder
Seidman, L. J., Doyle, A., Fried, R., Valera, E., Crum, K., & Matthews, L. (2004) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2003.12.005 · Cited by 95 · see citing works
Atomoxetine and Adult Attention-Deficit/Hyperactivity Disorder: The Effects of Comorbidity
Spencer, T. J., Faraone, S. V., Michelson, D., Adler, L. A., Reimherr, F. W., Glatt, S. J., & Biederman, J. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0312 · Cited by 94 · see citing works
Atomoxetine and Stroop Task Performance in Adult Attention-Deficit/Hyperactivity Disorder
Faraone, S. V., Biederman, J., Spencer, T., Michelson, D., Adler, L., Reimherr, F., & Seidman, L. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.664 · Cited by 89 · see citing works
Neurochemical Modulation of Prefrontal Cortical Function in Humans and Animals
Arnsten, A. F. T., & Robbins, T. W. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134971.003.0004 · Cited by 87 · see citing works
Self-citationWee, S., & Woolverton, W. L. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.03.010 · Cited by 85 · see citing works
Neuropharmacological modulation of cognition
Chamberlain, S. R., Müller, U., Robbins, T. W., & Sahakian, B. J. (2006) · Current Opinion in Neurology · doi:10.1097/01.wco.0000247613.28859.77 · Cited by 79 · see citing works
Self-citationAcute Yohimbine Increases Laboratory-Measured Impulsivity in Normal Subjects
Swann, A. C., Birnbaum, D., Hood, A. J., Dougherty, D. M., & Moeller, F. G. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.007 · Cited by 73 · see citing works
Stimulant medications: how to minimize their reinforcing effects?
VOLKOW, N. D. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.359 · Cited by 70 · see citing works
Ma, C.-L., Qi, X.-L., Peng, J.-Y., & Li, B.-M. (2003) · NeuroReport · doi:10.1097/01.wnr.0000070831.57864.7b · Cited by 69 · see citing works
Clinical pharmacology of tomoxetine, a potential antidepressant.
Zerbe, R. L., Rowe, H., Enas, G. G., Wong, D., Farid, N., & Lemberger, L. (1985) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20085-4 · Cited by 64 · see citing works
BETTER HUMANS? THE POLITICS OF HUMAN ENHANCEMENT AND LIFE EXTENSION
Miller, P. A., & Wilsdon, J. (2006) · DigitalGeorgetown (Georgetown University Library) · Cited by 63 · see citing works
Innovations and recent trends in the treatment of ADHD
Madaan, V., Kinnan, S., Daughton, J., & Kratochvil, C. J. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.9.1375 · Cited by 59 · see citing works
During, M. J., Bean, A. J., & Roth, R. H. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90698-7 · Cited by 56 · see citing works
Chouinard, G., Annable, L., & Bradwejn, J. (1984) · Psychopharmacology · doi:10.1007/bf00427436 · Cited by 50 · see citing works
Stahl, S. M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0201 · Cited by 49 · see citing works
Dowson, J. H., McLean, A. N., Bazanis, E., Toone, B., Young, S., Robbins, T. W., & Sahakian, B. J. (2004) · European Psychiatry · doi:10.1016/j.eurpsy.2003.07.010 · Cited by 46 · see citing works
Self-citationAttention Deficit/Hyperactivity Disorder
Sagvolden, T. (1999) · European Psychologist · doi:10.1027//1016-9040.4.2.109 · Cited by 43 · see citing works
Stahl, S. M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0101 · Cited by 42 · see citing works
Attention deficit hyperactivity disorder in adults
Sachdev, P. S. (1999) · Psychological Medicine · doi:10.1017/s003329179800720x · Cited by 40 · see citing works
Integrative neuroscience approach to predict ADHD stimulant response
Hermens, D. F., ROWE, D. L., Gordon, E., & Williams, L. M. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.5.753 · Cited by 38 · see citing works
Young, E. S., Perros, P., Price, G. W., & Sadler, T. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00075-e · Cited by 37 · see citing works
Atomoxetine increases salivary cortisol in healthy volunteers
Chamberlain, S. R., Müller, U., Cleary, S., Robbins, T. W., & Sahakian, B. J. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106075274 · Cited by 28 · see citing works
Self-citationThe neuroscience of ADHD: multidisciplinary perspectives on a complex developmental disorder
Sonuga-Barke, E. J. S., & Sergeant, J. A. (2005) · Developmental Science · doi:10.1111/j.1467-7687.2005.00396.x · Cited by 21 · see citing works
Attention-deficit scales for adults (ADSA)
Triolo, S. J., & Murphy, K. R. (1996) · Brunner/Mazel eBooks · Cited by 8 · see citing works
Pharmacological Treatments for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults
Dowson, J. H. (2006) · Current Psychiatry Reviews · doi:10.2174/157340006778018157 · Cited by 5 · see citing works
Self-citationThe Cognition-Enhanced Classroom
Turner, D., & Sahakian, B. J. (2006) · DigitalGeorgetown (Georgetown University Library) · Cited by 5 · see citing works
Self-citationAttention-deficit scales for adults (ADSA)
Horton, A. M., & Reynolds, C. R. (1997) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/12.3.277 · Cited by 4 · see citing works
Flagged first, then by citations
2 of the 111 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Inhibition and the right inferior frontal cortex: one decade on
Aron, A. R., Robbins, T. W., & Poldrack, R. A. (2014) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2013.12.003 · Cited by 2,166 · see citing works
Self-citationInhibition and impulsivity: behavioral and neural basis of response control
Bari, A., & Robbins, T. W. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.005 · Cited by 1,921 · see citing works
Self-citationNeurocognitive endophenotypes of impulsivity and compulsivity: Towards dimensional psychiatry
Robbins, T. W., Gillan, C. M., Smith, D. G., de Wit, S., & Ersche, K. D. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.11.009 · Cited by 1,003 · see citing works
Self-citationThe Neuropsychopharmacology of Fronto-Executive Function: Monoaminergic Modulation
Robbins, T. W., & Arnsten, A. F. T. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135535 · Cited by 957 · see citing works
Self-citationThe role of impulsive behavior in drug abuse
Perry, J. L., & Carroll, M. E. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1173-0 · Cited by 805 · see citing works
Reaction time variability in ADHD: A meta-analytic review of 319 studies
Kofler, M. J., Rapport, M. D., Sarver, D. E., Raiker, J. S., Orban, S. A., Friedman, L. M., & Kolomeyer, E. G. (2013) · Clinical Psychology Review · doi:10.1016/j.cpr.2013.06.001 · Cited by 648 · see citing works
Probing compulsive and impulsive behaviors, from animal models to endophenotypes: A narrative review
Fineberg, N. A., Potenza, M. N., Chamberlain, S. R., Berlin, H. A., Menzies, L., Bechara, A., Sahakian, B. J., Robbins, T. W., Bullmore, E. T., & Hollander, E. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.185 · Cited by 654 · see citing works
Self-citationInhibitory control and psychopathology: A meta-analysis of studies using the stop signal task
LIPSZYC, J., & SCHACHAR, R. (2010) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617710000895 · Cited by 627 · see citing works
Arnsten, A. F. T., & Rubia, K. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.01.008 · Cited by 568 · see citing works
Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks
Arnsten, A. F. T. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.027 · Cited by 493 · see citing works
Fineberg, N. A., Chamberlain, S. R., Goudriaan, A. E., Stein, D. J., Vanderschuren, L. J. M. J., Gillan, C. M., Shekar, S., Gorwood, P. A. P. M., Voon, V., Morein-Zamir, S., et al. (2014) · CNS Spectrums · doi:10.1017/s1092852913000801 · Cited by 488 · see citing works
Self-citationSharma, A., & Couture, J. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028013510699 · Cited by 516 · see citing works
A computational model of inhibitory control in frontal cortex and basal ganglia.
Wiecki, T. V., & Frank, M. (2011) · Psychology Review · doi:10.1037/a0031542 · Cited by 401 · see citing works
Arnsten, A. F. T., & Pliszka, S. R. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.01.020 · Cited by 383 · see citing works
Alderson, R. M., Kasper, L. J., Hudec, K. L., & Patros, C. H. G. (2013) · Neuropsychology · doi:10.1037/a0032371 · Cited by 331 · see citing works
Chamberlain, S. R., Hampshire, A., Müller, U., Rubia, K., del Campo, N., Craig, K. J., Regenthal, R., Suckling, J., Roiser, J. P., Grant, J. E., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.014 · Cited by 300 · see citing works
Self-citationCognitive enhancement as a treatment for drug addictions
Sofuoglu, M., DeVito, E. E., Waters, A. J., & Carroll, K. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.021 · Cited by 296 · see citing works
Dissecting impulsivity and its relationships to drug addictions
Jentsch, J. D., Ashenhurst, J. R., Cervantes, M. C., Groman, S. M., James, A. S., & Pennington, Z. T. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12388 · Cited by 281 · see citing works
Eagle, D. M., & Baunez, C. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.003 · Cited by 280 · see citing works
Neural reserve, neuronal density in the locus ceruleus, and cognitive decline
Wilson, R. S., Nag, S., Boyle, P. A., Hizel, L. P., Yu, L., Buchman, A. S., Schneider, J. A., & Bennett, D. A. (2013) · Neurology · doi:10.1212/wnl.0b013e3182897103 · Cited by 275 · see citing works
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
Weintraub, D., Mavandadi, S., Mamikonyan, E., Siderowf, A. D., Duda, J. E., Hurtig, H. I., Colcher, A., Horn, S. S., Nazem, S., Ten Have, T. R., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ebdd79 · Cited by 255 · see citing works
Cognitive enhancement by drugs in health and disease
Husain, M., & Mehta, M. A. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2010.11.002 · Cited by 241 · see citing works
Gamo, N. J., Wang, M., & Arnsten, A. F. T. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.06.015 · Cited by 232 · see citing works
ADHD and the Prefrontal Cortex
Arnsten, A. F. T. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.01.018 · Cited by 220 · see citing works
Neuroscience of Behavioral and Pharmacological Treatments for Addictions
Potenza, M. N., Sofuoglu, M., Carroll, K. M., & Rounsaville, B. J. (2011) · Neuron · doi:10.1016/j.neuron.2011.02.009 · Cited by 214 · see citing works
Obeso, I., Wilkinson, L., Casabona, E., Bringas-Vega, M. L., Álvarez, M., Alvarez, L. M., Fuentes, N. P., Rodríguez‐Oroz, M., Macías, R. J., Obeso, J. A., et al. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2736-6 · Cited by 196 · see citing works
Prefrontal and monoaminergic contributions to stop-signal task performance in rats
Bari, A., Mar, A. C., Theobald, D. E., Elands, S. A., Oganya, K. C. N. A., Eagle, D. M., & Robbins, T. W. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1543-11.2011 · Cited by 188 · see citing works
Self-citationFineberg, N. A., Apergis-Schoute, A. M., Vaghi, M. M. S., Banca, P., Gillan, C. M., Voon, V., Chamberlain, S. R., Cinosi, E., Reid, J. E., Shahper, S., et al. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx088 · Cited by 186 · see citing works
Self-citationGroman, S. M., James, A. S., & Jentsch, J. D. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.08.008 · Cited by 176 · see citing works
Housden, C. R., O’Sullivan, S. S., Joyce, E. M., Lees, A. J., & Roiser, J. P. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.84 · Cited by 176 · see citing works
Linking ADHD to the Neural Circuitry of Attention
Mueller, A., Hong, D. S., Shepard, S., & Moore, T. (2017) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2017.03.009 · Cited by 158 · see citing works
Cognitive enhancement as a pharmacotherapy target for stimulant addiction
Sofuoglu, M. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02791.x · Cited by 158 · see citing works
Berridge, C. W., & Devilbiss, D. M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.023 · Cited by 160 · see citing works
Response Inhibition and Interference Control in Obsessive–Compulsive Spectrum Disorders
van Velzen, L. S., Vriend, C., de Wit, S. J., & van den Heuvel, O. A. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00419 · Cited by 159 · see citing works
A right hemisphere role in cognitive reserve
Robertson, I. H. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.028 · Cited by 155 · see citing works
Fronto-striatal circuits in response-inhibition: Relevance to addiction
Morein‐Zamir, S., & Robbins, T. W. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.012 · Cited by 155 · see citing works
Self-citationChamberlain, S. R., Robbins, T. W., Winder-Rhodes, S., Müller, U., Sahakian, B. J., Blackwell, A. D., & Barnett, J. H. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.019 · Cited by 178 · see citing works
Self-citationBeste, C., Steenbergen, L., Sellaro, R., Grigoriadou, S., Zhang, R., Chmielewski, W. X., Stock, A., & Colzato, L. S. (2016) · Brain stimulation · doi:10.1016/j.brs.2016.07.004 · Cited by 140 · see citing works
Christiansen, L., Beck, M. M., Bilenberg, N., Wienecke, J., Astrup, A. V., & Lundbye‐Jensen, J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060841 · Cited by 148 · see citing works
Targeting impulsivity in Parkinson’s disease using atomoxetine
Kehagia, A. A., Housden, C. R., Regenthal, R., Barker, R. A., Müller, U., Rowe, J. B., Sahakian, B. J., & Robbins, T. W. (2014) · Brain · doi:10.1093/brain/awu117 · Cited by 139 · see citing works
Self-citationNewman, L. A., Darling, J., & McGaughy, J. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1097-8 · Cited by 137 · see citing works
Fernando, A. B. P., Economidou, D., Theobald, D. E., Zou, M.-F., Newman, A. H., Spoelder, M., Caprioli, D., Moreno, M., Hipόlito, L., Aspinall, A. T., et al. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2408-z · Cited by 135 · see citing works
Self-citationMarsh, L., Biglan, K., Gerstenhaber, M., & Williams, J. R. (2008) · Movement Disorders · doi:10.1002/mds.22307 · Cited by 135 · see citing works
Trichotillomania: neurobiology and treatment
Chamberlain, S. R., Odlaug, B. L., Boulougouris, V., Fineberg, N. A., & Grant, J. E. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.02.002 · Cited by 126 · see citing works
Self-citationHains, A. B., & Arnsten, A. F. T. (2008) · Learning & Memory · doi:10.1101/lm.921708 · Cited by 127 · see citing works
Endophenotypes of obsessive-compulsive disorder: rationale, evidence and future potential
Chamberlain, S. R., & Menzies, L. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.36 · Cited by 123 · see citing works
Self-citationCowen, P. J., & Sherwood, A. C. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113482531 · Cited by 122 · see citing works
Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys
Seu, E., Lang, A., Rivera, R. J., & Jentsch, J. D. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1250-4 · Cited by 121 · see citing works
Sahakian, B. J., Brühl, A. B., Cook, J. L., Killikelly, C., Savulich, G., Piercy, T., Hafizi, S., Pérez, J., Fernández-Egea, E., Suckling, J., et al. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0214 · Cited by 118 · see citing works
Self-citationSelective serotonin reuptake inhibition modulates response inhibition in Parkinson’s disease
Ye, Z., Altena, E., Nombela, C., Housden, C. R., Maxwell, H., Rittman, T., Huddleston, C., Rae, C. L., Regenthal, R., Sahakian, B. J., et al. (2014) · Brain · doi:10.1093/brain/awu032 · Cited by 118 · see citing works
Self-citationCubillo, A., Smith, A. B., Barrett, N., Giampietro, V., Brammer, M. J., Simmons, A., & Rubia, K. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhs296 · Cited by 116 · see citing works
Schulz, K. P., Fan, J., Bédard, A.-C. V., Clerkin, S. M., Ivanov, I., Tang, C. Y., Halperin, J. M., & Newcorn, J. H. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2053 · Cited by 114 · see citing works
del Campo, N., Fryer, T. D., Hong, Y. T., Smith, R., Brichard, L., Acosta-Cabronero, J., Chamberlain, S. R., Tait, R., Izquierdo, D., Regenthal, R., et al. (2013) · Brain · doi:10.1093/brain/awt263 · Cited by 113 · see citing works
Self-citationNeuroethical issues in cognitive enhancement
Sahakian, B. J., & Morein‐Zamir, S. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109106926 · Cited by 108 · see citing works
Self-citationPharmacological Enhancement of Memory and Executive Functioning in Laboratory Animals
Floresco, S., & Jentsch, J. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.158 · Cited by 109 · see citing works
Gold, B. T. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.12.006 · Cited by 110 · see citing works
Bari, A., & Robbins, T. W. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3141-6 · Cited by 105 · see citing works
Self-citationRomero, M. J., Asensio, S., Palau, C., Sanchez, A., & Romero, F. J. (2010) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2009.07.004 · Cited by 103 · see citing works
Improving Response Inhibition in Parkinson’s Disease with Atomoxetine
Ye, Z., Altena, E., Nombela, C., Housden, C. R., Maxwell, H., Rittman, T., Huddleston, C., Rae, C. L., Regenthal, R., Sahakian, B. J., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.024 · Cited by 104 · see citing works
Self-citationKenemans, J. L., & Kähkönen, S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.157 · Cited by 104 · see citing works
Atomoxetine restores the response inhibition network in Parkinson’s disease
Rae, C. L., Nombela, C., Rodríguez, P. V., Ye, Z., Hughes, L. E., Jones, P. S., Ham, T. E., Rittman, T., Coyle-Gilchrist, I. T. S., Regenthal, R., et al. (2016) · Brain · doi:10.1093/brain/aww138 · Cited by 98 · see citing works
Self-citationBroos, N., Diergaarde, L., Schoffelmeer, A. N. M., Pattij, T., & Vries, T. J. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.323 · Cited by 96 · see citing works
Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease
Napier, T. C., Corvol, J., Grace, A. A., Roitman, J. D., Rowe, J. B., Voon, V., & Strafella, A. P. (2014) · Movement Disorders · doi:10.1002/mds.26068 · Cited by 94 · see citing works
Cross‐species studies of cognition relevant to drug discovery: a translational approach
Robbins, T. W. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13826 · Cited by 94 · see citing works
Self-citationDing, Y., Naganawa, M., Gallezot, J., Nabulsi, N., Lin, S.-F., Ropchan, J. R., Weinzimmer, D. P., McCarthy, T. J., Carson, R. E., Huang, Y. H., et al. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.08.001 · Cited by 93 · see citing works
Gau, S. S.-F., & Shang, C.-Y. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990836 · Cited by 91 · see citing works
Hoffmann, M. W. (2013) · ISRN Neurology · doi:10.1155/2013/892459 · Cited by 90 · see citing works
Carmona, S., Hoekzema, E., Ramos‐Quiroga, J. A., Richarte, V., Canals, C., Bosch, R., Rovira, M., Carlos Soliva, J., Bulbena, A., Tobeña, A., et al. (2012) · Human Brain Mapping · doi:10.1002/hbm.21368 · Cited by 89 · see citing works
Driving and attention deficit hyperactivity disorder
Fuermaier, A., Tucha, L., Evans, B. L., Koerts, J., de Waard, D., Brookhuis, K., Aschenbrenner, S., Thome, J., Lange, K., & Tucha, O. (2015) · Journal of neural transmission · doi:10.1007/s00702-015-1465-6 · Cited by 81 · see citing works
Smallwood, J., Brown, K., Baird, B., Mrazek, M. D., Franklin, M. S., & Schooler, J. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033706 · Cited by 87 · see citing works
Rogers, R., Moeller, F., Swann, A., & Clark, L. (2010) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01216.x · Cited by 92 · see citing works
Self-citationPharmacotherapy for social anxiety disorder (SAnD)
Williams, T., Hattingh, C. J., Kariuki, C. M., Tromp, S. A., van Balkom, A. J., Ipser, J. C., & Stein, D. J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001206.pub3 · Cited by 84 · see citing works
Paterson, N. E., Ricciardi, J., Wetzler, C., & Hanania, T. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.10.001 · Cited by 83 · see citing works
Translational approaches to obsessive‐compulsive disorder: from animal models to clinical treatment
Fineberg, N. A., Chamberlain, S. R., Hollander, E., Boulougouris, V., & Robbins, T. W. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01422.x · Cited by 81 · see citing works
Self-citationObeso, I., Wilkinson, L., & Jahanshahi, M. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2793-x · Cited by 81 · see citing works
The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder
Arnsten, A. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.133 · Cited by 80 · see citing works
Chmielewski, W. X., Mückschel, M., Ziemssen, T., & Beste, C. (2016) · Human Brain Mapping · doi:10.1002/hbm.23344 · Cited by 79 · see citing works
Motor inhibition and cognitive flexibility in pathologic skin picking
Odlaug, B. L., Chamberlain, S. R., & Grant, J. E. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.11.008 · Cited by 76 · see citing works
Self-citationPaterson, N. E., Wetzler, C., Hackett, A., & Hanania, T. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001635 · Cited by 74 · see citing works
Cubillo, A., Smith, A. B., Barrett, N., Giampietro, V., Brammer, M., Simmons, A., & Rubia, K. (2014) · Psychological Medicine · doi:10.1017/s0033291713000676 · Cited by 88 · see citing works
Neural Correlates of Error Monitoring Modulated by Atomoxetine in Healthy Volunteers
Graf, H., Abler, B., Freudenmann, R. W., Beschoner, P., Schaeffeler, E., Spitzer, M., Schwab, M. G., & Grön, G. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.10.018 · Cited by 73 · see citing works
Boulinguez, P., Ballanger, B., Granjon, L., & Benraïss, A. (2009) · Clinical Neurophysiology · doi:10.1016/j.clinph.2009.02.167 · Cited by 70 · see citing works
Reducing substance use during adolescence: a translational framework for prevention
Stanis, J. J., & Andersen, S. L. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3393-1 · Cited by 69 · see citing works
A review of the 5-Choice Serial Reaction Time (5-CSRT) task in different vertebrate models
Fizet, J., Cassel, J., Kelche, C. R., & Meunier, H. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.08.027 · Cited by 68 · see citing works
Mayer, K., Blume, F., Wyckoff, S., Brokmeier, L., & Strehl, U. (2016) · Clinical Neurophysiology · doi:10.1016/j.clinph.2015.11.013 · Cited by 66 · see citing works
Morein‐Zamir, S., Dodds, C., van Hartevelt, T. J., Schwarzkopf, W., Sahakian, B., Müller, U., & Robbins, T. (2014) · Human Brain Mapping · doi:10.1002/hbm.22539 · Cited by 65 · see citing works
Self-citationPertermann, M., Mückschel, M., Adelhöfer, N., Ziemssen, T., & Beste, C. (2019) · Journal of Neurophysiology · doi:10.1152/jn.00701.2018 · Cited by 65 · see citing works
Future pharmacological treatments for substance use disorders
Forray, A., & Sofuoglu, M. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04474.x · Cited by 65 · see citing works
Manza, P., Amandola, M., Tatineni, V., Li, C.-S. R., & Leung, H. (2017) · npj Parkinson s Disease · doi:10.1038/s41531-017-0024-2 · Cited by 63 · see citing works
Bedard, A., Stein, M. A., Halperin, J. M., Krone, B., Rajwan, E., & Newcorn, J. H. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12272 · Cited by 62 · see citing works
Brain γ‐aminobutyric acid: a neglected role in impulsivity
Hayes, D. J., Jupp, B., Sawiak, S. J., Merlo, E., Caprioli, D., & Dalley, J. W. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12485 · Cited by 63 · see citing works
Ni, H., Shang, C., Gau, S. S., Lin, Y., Huang, H., & Yang, L.-K. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000357 · Cited by 61 · see citing works
Pharmacological manipulations of interval timing using the peak procedure in male C3H mice
Balcı, F., Ludvig, E. A., Gibson, J. M., Allen, B. D., Frank, K. M., Kapustinski, B. J., Fedolak, T. E., & Brunner, D. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1248-y · Cited by 61 · see citing works
Senkowski, D., Ziegler, T., Singh, M., Heinz, A., He, J., Silk, T., & Lorenz, R. C. (2024) · Neuropsychology Review · doi:10.1007/s11065-023-09592-5 · Cited by 59 · see citing works
The Neurobiology of Attention-Deficit/Hyperactivity Disorder
Chamberlain, S. R., Robbins, T. W., & Sahakian, B. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.009 · Cited by 56 · see citing works
Self-citationProblems of Self-Concept in a Patient Sample of Hypersexual Men With Attention-Deficit Disorder
Reid, R. C., Carpenter, B. N., Gilliland, R., & Karim, R. (2010) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e3181e6ad32 · Cited by 57 · see citing works
Atomoxetine facilitates attentional set shifting in adolescent rats
Cain, R. E., Wasserman, M. C., Waterhouse, B. D., & McGaughy, J. A. (2011) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2011.04.003 · Cited by 55 · see citing works
The ethics of elective psychopharmacology
Mohamed, A. D., & Sahakian, B. J. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571100037x · Cited by 55 · see citing works
Self-citationAdelhöfer, N., Mückschel, M., Teufert, B., Ziemssen, T., & Beste, C. (2019) · Brain Structure and Function · doi:10.1007/s00429-019-01839-3 · Cited by 57 · see citing works
Bahnfleth, C. L., Strupp, B. J., Caudill, M. A., & Canfield, R. L. (2021) · The FASEB Journal · doi:10.1096/fj.202101217r · Cited by 55 · see citing works
- Authors
- Chamberlain, S. R., del Campo, N., Dowson, J., Müller, U., Clark, L., Robbins, T. W., & Sahakian, B. J.
- Affiliations
- University of Cambridge (GB)
- Utrecht University (NL)
- Corresponding author
- Chamberlain, Samuel R.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 62
- Issue
- 9
- Pages
- 977-984
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2005105013
- Cited by
- 288
- References
- 111
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 8 · 2021: 12 · 2020: 8 · 2019: 11 · 2018: 8 · 2017: 15 · 2016: 17 · 2015: 13 · 2014: 27 · 2013: 27 · 2012: 30
- FWCI
- 12.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Funders
- Wellcome Trust (076274/Z04/Z)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- atomoxetine, attention deficit hyperactivity disorder, adults, response inhibition, inhibitory control, norepinephrine reuptake inhibitors, single-dose pharmacokinetics, stop-signal task, sustained attention, spatial working memory, set-shifting, prefrontal cortex, impulsivity, cognitive effects
- MeSH terms
- Atomoxetine Hydrochloride, Administration, Oral, Adult, Analysis of Variance, Attention, Attention Deficit Disorder with Hyperactivity, Cognition, Double-Blind Method, Female, Humans, Inhibition, Psychological, Male, Memory, Short-Term, Neuropsychological Tests, Propylamines, Reaction Time, Time Factors, Case-Control Studies, Cross-Over Studies, Adrenergic Uptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
